About rimegepan t
CGRP receptor antagonist
Used for
- Acute treatment of migraine, with or without aura, in adults.
- Prevention of episodic migraine in adults.
Usual adult dose
Acute migraine: 75 mg once as needed; maximum 75 mg in 24 hours. Prevention: 75 mg every other day.
Common side effects
- Nausea
- Indigestion
- Allergic reactions, including rash or breathing difficulty
Important warnings
- Avoid strong CYP3A4 inhibitors or inducers and potent P-glycoprotein inhibitors.
- A second dose within 48 hours is not recommended with certain interacting medicines.
- Serious allergic reactions may occur, sometimes days after taking it.
Pregnancy
Human pregnancy data are limited; safety has not been established.
Breastfeeding
Small amounts pass into breast milk; effects on infants are uncertain.
Interactions
- Strong CYP3A4 inhibitors may increase rimegepant levels.
- Strong or moderate CYP3A inducers may reduce its effectiveness.
- Potent P-glycoprotein inhibitors may increase exposure; avoid another dose within 48 hours.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.